| Income Statement | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Research and development | 141,169 | 184,367 | ||
| General and administrative | 28,213 | 27,334 | ||
| Total operating expenses | 169,382 | 211,701 | ||
| Loss from operations | -169,382 | -211,701 | ||
| Other (expense) income, net | -3,840 | 13,815 | ||
| Loss before provision (benefit) for income taxes | -173,222 | -197,886 | ||
| Provision (benefit) for income taxes | 221 | 261 | ||
| Net loss | -173,443 | -198,147 | ||
| Other comprehensive income (loss), net of tax | 39 | -76 | ||
| Comprehensive loss | -173,404 | -198,223 | ||
| Net loss per share basic (in dollars per share) | -1.64 | -1.94 | ||
| Net loss per share diluted (in dollars per share) | -1.64 | -1.94 | ||
| Weighted average common shares outstandingbasic (in shares) | 105,815,038 | 102,372,820 | ||
| Weighted average common shares outstandingdiluted (in shares) | 105,815,038 | 102,372,820 | ||
Biohaven Ltd. (BHVN)
Biohaven Ltd. (BHVN)